Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

被引:66
作者
Dote, H
Toyooka, S [1 ]
Tsukuda, K
Yano, M
Ota, T
Murakami, M
Naito, M
Toyota, M
Gazdar, AF
Shimizu, N
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Canc & Thorac Surg, Okayama 7008558, Japan
[2] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
[4] Sapporo Med Univ, Dept Mol Biol, Canc Res Inst, Sapporo, Hokkaido 0608543, Japan
[5] Sapporo Med Univ, Dept Internal Med 1, Canc Res Inst, Sapporo, Hokkaido 0608543, Japan
关键词
methylation; hDAB2IP; gastrointestinal tumour; histone acetylation; methylation specific PCR;
D O I
10.1038/sj.bjc.6602458
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human DOC-2/DAB2 interactive protein (hDAB2IP) gene is a novel member of the Ras GTPase-activating family and has been demonstrated to be a tumour-suppressor gene inactivated by methylation in several cancers. In this study, we analysed the methylation and expression status of hDAB2IP in gastrointestinal tumours. The promoter region of hDAB2IP was divided into two regions (m2a and m2b) based on our previous report, and the methylation status was determined by bisulphite DNA sequencing in gastric cancer cell lines. The gene expression was semiquantified by real-time RT-PCR, and the results indicated that the m2b promoter region might be an authentic methylation-mediated key regulator of the gene expression. Based on the sequence data, we developed a methylation-specific PCR (MSP) for the m2a and m2b regions and applied it to the samples. Methylation-specific PCR revealed aberrant methylation in the m2a region in eight of 12 gastric cancer cell lines (67%), 16 of 35 gastric cancer tissues (46%) and 29 of 60 colorectal cancer tissues (48%), and in the m2b region in eight of 12 cell lines ( 67%), 15 of 35 gastric cancer tissues (43%) and 28 of 60 colorectal cancer tissues (47%). On the other hand, seven (12%) and 11 (19%) of 59 gastrointestinal nonmalignant mucosal specimens showed methylation in the m2a and m2b regions, respectively, suggesting that hDAB2IP methylation might play a causative role in carcinogenesis. The 5-aza-2 '-deoxycytidine treatment restored the gene expression in the m2b-methylated cell lines, confirming that the methylation caused gene downregulation. We also examined the relationship between hDAB2IP methylation and the clinicopathological features in patients with primary tumours, and determined that methylation in the m2b region was associated with location of the tumour in the stomach. In summary, our results demonstrated that hDAB2IP methylation is frequently present in gastrointestinal tumours and that the resulting gene silencing plays an important role in gastrointestinal carcinogenesis.
引用
收藏
页码:1117 / 1125
页数:9
相关论文
共 34 条
[1]   DNA hypermethylation in tumorigenesis - epigenetics joins genetics [J].
Baylin, SB ;
Herman, JG .
TRENDS IN GENETICS, 2000, 16 (04) :168-174
[2]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107
[3]   Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines [J].
Chen, H ;
Toyooka, S ;
Gazdar, AF ;
Hsieh, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3121-3130
[4]   Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia:: Cloning and characterization [J].
Chen, H ;
Pong, RC ;
Wang, Z ;
Hsieh, JT .
GENOMICS, 2002, 79 (04) :573-581
[5]   Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer [J].
Dote, H ;
Toyooka, S ;
Tsukuda, K ;
Yano, M ;
Ouchida, M ;
Doihara, H ;
Suzuki, M ;
Chen, H ;
Hsieh, JT ;
Gazdar, AF ;
Shimizu, N .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :2082-2089
[6]   DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases [J].
Fulop, V ;
Colitti, CV ;
Genest, D ;
Berkowitz, RS ;
Yiu, GK ;
Ng, SW ;
Szepesi, J ;
Mok, SC .
ONCOGENE, 1998, 17 (04) :419-424
[7]   CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability [J].
Hawkins, N ;
Norrie, M ;
Cheong, K ;
Mokany, E ;
Ku, SL ;
Meagher, A ;
O'Connor, T ;
Ward, R .
GASTROENTEROLOGY, 2002, 122 (05) :1376-1387
[8]   Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands [J].
Herman, JG ;
Graff, JR ;
Myohanen, S ;
Nelkin, BD ;
Baylin, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9821-9826
[9]   Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines [J].
Honda, T ;
Tamura, G ;
Waki, T ;
Jin, Z ;
Sato, K ;
Motoyama, T ;
Kawata, S ;
Kimura, W ;
Nishizuka, S ;
Murakami, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (08) :857-860
[10]   Cancer epigenetics comes of age [J].
Jones, PA ;
Laird, PW .
NATURE GENETICS, 1999, 21 (02) :163-167